TrialActa diabetologica2015

Atazanavir improves cardiometabolic measures but not vascular function in patients with long-standing type 1 diabetes mellitus.

Jessica Milian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.